124 related articles for article (PubMed ID: 37925875)
1. Correlation between the CEM imaging characteristics and different molecular subtypes of breast cancer.
Li N; Gong W; Xie Y; Sheng L
Breast; 2023 Dec; 72():103595. PubMed ID: 37925875
[TBL] [Abstract][Full Text] [Related]
2. Association between quantitative and qualitative image features of contrast-enhanced mammography and molecular subtypes of breast cancer.
Wang S; Wang Z; Li R; You C; Mao N; Jiang T; Wang Z; Xie H; Gu Y
Quant Imaging Med Surg; 2022 Feb; 12(2):1270-1280. PubMed ID: 35111622
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI Features of Breast Cancer Molecular Subtypes.
Szep M; Pintican R; Boca B; Perja A; Duma M; Feier D; Fetica B; Eniu D; Dudea SM; Chiorean A
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556918
[TBL] [Abstract][Full Text] [Related]
4. Correlation study between the magnetic resonance imaging features of breast cancer and expression of immune molecular subtypes.
Long N; Ran C; Sun J; Hao CJ; Sui YB; Li J; Shi YX; Zou ZX; Qu YH
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11518-11527. PubMed ID: 33275218
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
6. Correlation between imaging features and molecular subtypes of breast cancer in young women (≤30 years old).
Huang J; Lin Q; Cui C; Fei J; Su X; Li L; Ma J; Zhang M
Jpn J Radiol; 2020 Nov; 38(11):1062-1074. PubMed ID: 32562180
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced cone beam breast CT features of breast cancers: correlation with immunohistochemical receptors and molecular subtypes.
Ma Y; Liu A; O'Connell AM; Zhu Y; Li H; Han P; Yin L; Lu H; Ye Z
Eur Radiol; 2021 Apr; 31(4):2580-2589. PubMed ID: 33009590
[TBL] [Abstract][Full Text] [Related]
8. Role of mammogram and ultrasound imaging in predicting breast cancer subtypes in screening and symptomatic patients.
Ian TWM; Tan EY; Chotai N
World J Clin Oncol; 2021 Sep; 12(9):808-822. PubMed ID: 34631444
[TBL] [Abstract][Full Text] [Related]
9. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
[TBL] [Abstract][Full Text] [Related]
10. Differences in the Immune Response of the Nonmetastatic Axillary Lymph Nodes between Triple-Negative and Luminal A Breast Cancer Surrogate Subtypes.
López C; Gibert-Ramos A; Bosch R; Korzynska A; García-Rojo M; Bueno G; García-Fontgivell JF; Martínez González S; Fontoura L; Gras Navarro A; Sauras Colón E; Casanova Ribes J; Roszkowiak L; Roso A; Berenguer M; Llobera M; Baucells J; Lejeune M
Am J Pathol; 2021 Mar; 191(3):545-554. PubMed ID: 33309504
[TBL] [Abstract][Full Text] [Related]
11. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?
Truong PT; Sadek BT; Lesperance MF; Alexander CS; Shenouda M; Raad RA; Taghian AG
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):57-64. PubMed ID: 24161421
[TBL] [Abstract][Full Text] [Related]
12. Imaging features of triple-negative breast cancers according to androgen receptor status.
Candelaria RP; Adrada BE; Wei W; Thompson AM; Santiago L; Lane DL; Huang ML; Arribas EM; Rauch GM; Symmans WF; Gilcrease MZ; Huo L; Lim B; Ueno NT; Moulder SL; Yang WT
Eur J Radiol; 2019 May; 114():167-174. PubMed ID: 31005169
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer in very young women (<30 years): Correlation of imaging features with clinicopathological features and immunohistochemical subtypes.
An YY; Kim SH; Kang BJ; Park CS; Jung NY; Kim JY
Eur J Radiol; 2015 Oct; 84(10):1894-902. PubMed ID: 26198117
[TBL] [Abstract][Full Text] [Related]
14. Association between molecular subtypes and lymph node status in invasive breast cancer.
Si C; Jin Y; Wang H; Zou Q
Int J Clin Exp Pathol; 2014; 7(10):6800-6. PubMed ID: 25400761
[TBL] [Abstract][Full Text] [Related]
15. Clinical prognostic evaluation of immunocytes in different molecular subtypes of breast cancer.
Zenan H; Zixiong L; Zhicheng Y; Mei H; Xiongbin Y; Tiantian W; Min D; Renbin L; Changchang J
J Cell Physiol; 2019 Nov; 234(11):20584-20602. PubMed ID: 31016756
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Clinicopathological Features and Molecular Markers in Bahraini Women With Breast Cancer.
AlZaman A; Ali E; Mohamad B; Islam M; AlZaman E; AlZaman Y
Gulf J Oncolog; 2020 Jan; 1(32):19-25. PubMed ID: 32342914
[TBL] [Abstract][Full Text] [Related]
18. Molecular subtypes of invasive breast carcinoma of no special type, their correlation with histopathological features, Ki 67 index and tumor budding: A retrospective comparative study.
Radhakrishnan N; Mathews A; Rajeev KR; Nair PS; Bhargavan R; Viswanathan AJ
Indian J Pathol Microbiol; 2022; 65(4):772-780. PubMed ID: 36308179
[TBL] [Abstract][Full Text] [Related]
19. Contrast-Enhanced Mammography Radiomics Analysis for Preoperative Prediction of Breast Cancer Molecular Subtypes.
Zhu S; Wang S; Guo S; Wu R; Zhang J; Kong M; Pan L; Gu Y; Yu S
Acad Radiol; 2023 Dec; ():. PubMed ID: 38142176
[TBL] [Abstract][Full Text] [Related]
20. MR Imaging Findings in Molecular Subtypes of Breast Cancer According to BIRADS System.
Navarro Vilar L; Alandete Germán SP; Medina García R; Blanc García E; Camarasa Lillo N; Vilar Samper J
Breast J; 2017 Jul; 23(4):421-428. PubMed ID: 28067435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]